Literature DB >> 22494666

Secretory carcinoma of the breast: results from the survival, epidemiology and end results database.

David P Horowitz1, Charu S Sharma, Eileen Connolly, Daniela Gidea-Addeo, Israel Deutsch.   

Abstract

BACKGROUND: Secretory carcinoma of the breast is a rare breast cancer that is associated with incidence at a young age and an indolent course. The role for breast conservation and adjuvant radiation is unknown.
METHODS: The SEER database was reviewed and 83 patients were identified with secretory carcinoma of the breast between the years 1983 and 2007. Baseline characteristics were compared with χ(2) or Fisher's exact test. Overall survival (OS) and cause-specific survival (CSS) were estimated using the Kaplan-Meier method. Analyses were performed using PASW Statistics, version 18.
RESULTS: Median follow-up was 70 months. Median patient age was 53 years (range 11-86 years). 29 patients (34.9%) had involved regional lymph nodes. 39 patients (47.0%) underwent lumpectomy and 44 patients (53.0%) underwent mastectomy. 35 patients (42.2%) received radiation. Patients receiving radiation were more likely to have undergone lumpectomy, and the use of radiation increased over time. 5-year OS was 87.2%; 10-year OS was 76.5%. 5-year CSS was 94.4%; 10-year CSS was 91.4%. Among the lumpectomy patients, 25 patients (64.1%) received radiation. For lumpectomy patients, those who did not receive radiation had a 5-year OS of 92.9% and 10-year OS of 72.2% while patients who did receive radiation had a 5-year OS of 95.5% and 10-year OS of 85.9%. Only 1 patient treated with lumpectomy only died of cancer (92.9% CSS) and no patients treated with lumpectomy and radiation died of cancer (100% CSS).
CONCLUSIONS: Secretory carcinoma of the breast commonly occurs at a later age than previously recognized, and is associated with good long-term survival.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22494666     DOI: 10.1016/j.breast.2012.02.013

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  31 in total

1.  Successful Targeted Therapy of Refractory Pediatric ETV6-NTRK3 Fusion-Positive Secretory Breast Carcinoma.

Authors:  Neerav Shukla; Stephen S Roberts; Mollah O Baki; Qazi Mushtaq; Paul E Goss; Ben H Park; Gunes Gundem; Ken Tian; Heather Geiger; Kristie Redfield; Gerald Behr; Ryma Benayed; Ahmet Zehir; Jaclyn F Hechtman; Robert B Darnell; Elli Papaemmanuil; Marc Ladanyi; Nora Ku; Andrew L Kung; José Baselga; Alexander Drilon; David M Hyman
Journal:  JCO Precis Oncol       Date:  2017-08-18

Review 2.  The Spectrum of Triple-Negative Breast Disease: High- and Low-Grade Lesions.

Authors:  Felipe C Geyer; Fresia Pareja; Britta Weigelt; Emad Rakha; Ian O Ellis; Stuart J Schnitt; Jorge S Reis-Filho
Journal:  Am J Pathol       Date:  2017-07-20       Impact factor: 4.307

3.  Secretory carcinoma of breast in a patient treated for differentiated thyroid carcinoma-a diagnostic dilemma.

Authors:  S Alagu Ganesh; Madhu Muralee; Renu Sukumaran; M Iqbal Ahamed
Journal:  Indian J Surg Oncol       Date:  2014-08-02

4.  Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas.

Authors:  Gregor Krings; Nancy M Joseph; Gregory R Bean; David Solomon; Courtney Onodera; Eric Talevich; Iwei Yeh; James P Grenert; Elizabeth Hosfield; Emily D Crawford; Richard C Jordan; Annemieke van Zante; Charles Zaloudek; Sandra J Shin; Yunn-Yi Chen
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 5.  Mammary analog secretory carcinoma of salivary gland with high-grade histology arising in hard palate, report of a case and review of literature.

Authors:  Wenyi Luo; Sarah W Lindley; Peter H Lindley; Gregory A Krempl; Raja R Seethala; Kar-Ming Fung
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01

6.  Prognostic and predictive parameters in breast pathology: a pathologist's primer.

Authors:  Kimberly H Allison
Journal:  Mod Pathol       Date:  2020-11-05       Impact factor: 7.842

Review 7.  Problematic breast tumors reassessed in light of novel molecular data.

Authors:  Fresia Pareja; Britta Weigelt; Jorge S Reis-Filho
Journal:  Mod Pathol       Date:  2020-10-06       Impact factor: 7.842

8.  Secretory breast cancer. Case report.

Authors:  A Lombardi; S Maggi; L Bersigotti; G Lazzarin; E Nuccetelli; C Amanti
Journal:  G Chir       Date:  2013-04

Review 9.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

10.  Secretory carcinoma of the breast, commonly exhibits the features of low grade, triple negative breast carcinoma- A Case report with updated review of literature.

Authors:  Nirmalya Banerjee; Devmalya Banerjee; Neha Choudhary
Journal:  Autops Case Rep       Date:  2020-12-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.